Greenrise Announces Record Sales for Q2 and Comments on Positive Developments regarding the Legislation of Adult-Use Cannabis in Germany

VANCOUVER, Canada and HAMBURG, Germany – August 8th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise” and “the Company”) is pleased to provide preliminary, unaudited second…

Continue ReadingGreenrise Announces Record Sales for Q2 and Comments on Positive Developments regarding the Legislation of Adult-Use Cannabis in Germany

Greenrise Provides Update on CannaCare’s Sales Growth and First Quarter Results

HAMBURG, Germany – June 20th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise”), which operates in the German CBD wellbeing and medical cannabis market announces its…

Continue ReadingGreenrise Provides Update on CannaCare’s Sales Growth and First Quarter Results

Greenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

HAMBURG, Germany – May 11th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise''), which serves the medical and CBD cannabis market in Germany and CannaCare Health…

Continue ReadingGreenrise Announces Appointment of Frank Otto to the Board of Directors and Closing of the Acquisition of Control of CannaCare Health GmbH

Greenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors 

HAMBURG, Germany – April 5th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise”), which serves the medical and CBD cannabis market in Germany, and CannaCare Health…

Continue ReadingGreenrise Advances its Leadership Position in Germany with the Acquisition of a Majority Interest in CannaCare Health GmbH and the Appointment of Frank Otto to its Board of Directors 

Greenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

HAMBURG, Germany, and PERTH, Australia – January 18th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) a distributor of medical and CBD wellness cannabis products…

Continue ReadingGreenrise Global’s Medical Cannabis Subsidiary, AMP Alternative Medical Products GmbH becomes Exclusive Distribution Partner of a Selection of Little Green Pharma Extracts in Germany

Greenrise Global’s Medical Cannabis Subsidiary, ​​AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany

HAMBURG and BENSHEIM, Germany – January 12th, 2022, Greenrise Global Brands Inc. (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”), a distributor of medical and CBD wellness cannabis products in…

Continue ReadingGreenrise Global’s Medical Cannabis Subsidiary, ​​AMP Alternative Medical Products GmbH Announces the Beginning of Dronabinol Sales in Germany

Greenrise Global’s Supports Germany’s Approach 
to Cannabis Legalization for Adult Use

BERLIN, ERFURT, Germany – November 25th, 2021, Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) would like to comment on…

Continue ReadingGreenrise Global’s Supports Germany’s Approach 
to Cannabis Legalization for Adult Use